Med Holdings Group Advances Strategic Growth Through Clinical Partnership and Digital Expansion

Med Holdings Group Inc. has entered advanced negotiations with nationally recognized urology and sexual wellness specialist Dr. Harvey Samowitz, a strategic move designed to enhance the company's clinical expertise during a period of rapid expansion. Dr. Samowitz brings over three decades of experience in urology, sexual medicine, and pelvic health, with board certification from the American Board of Urology and subspecialty certification in Female Pelvic Medicine and Reconstructive Surgery. His professional affiliations include the American Urological Association, American College of Surgeons, and Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction, among others.

Chief Executive Officer Jessica Miller emphasized that aligning with elite medical leadership represents a core component of the company's growth strategy. The potential involvement of Dr. Samowitz reflects Med Holdings Group's commitment to building a nationally recognized brand while creating sustained shareholder value. This clinical partnership coincides with several corporate initiatives aimed at accelerating the company's market position and operational scale.

Med Holdings Group is actively negotiating for two additional locations in Jupiter, Florida and Doral, Florida, markets that align with the company's demographic strategy targeting high-income populations. Management anticipates these expansions will strengthen recurring revenue streams and enhance regional brand dominance. Concurrently, the company is fast-tracking its audit process while advancing a FINRA name change and ticker symbol modification to improve transparency and market visibility.

The company has officially launched its enhanced national platform at TotallBody.com, significantly expanding its addressable market beyond physical locations. This digital infrastructure provides immediate national brand exposure, access to underserved markets, and scalable engagement for current services and future vertical expansion. Management views this platform as foundational to building a nationally scalable healthcare delivery system.

Market momentum has been substantial, with the company's stock appreciating more than 500% over the past twelve months and market capitalization exceeding $3 million. This growth reflects increasing investor recognition of the company's strategic direction and execution capabilities. With committed expansion capital, a clear multi-location rollout strategy, accelerating compliance milestones, expanding clinical leadership, and scalable digital infrastructure, Med Holdings Group believes it is strategically positioned for continued operational and market growth throughout 2026 and beyond.